SER - Serina Therapeutics Inc.
Close
7.98
-0.020 -0.251%
Share volume: 3,785
Last Updated: Fri 30 Aug 2024 10:30:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$8.00
-0.02
-0.25%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-10 | 2023-03-31 | 2023-05-12 | 2023-08-14 | 2023-11-14 | 2024-03-22 | 2024-05-14 | |
| Cash flow financing | 2.000 M | 1.000 M | 1.500 M | 11.500 M | 2.000 M | 2.000 M | 2.000 M | 2.728 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -1.746 M | -1.236 M | -1.321 M | -1.865 M | -2.019 M | -1.864 M | -2.052 M | -1.577 M | |
| Net income | -2.618 M | -2.435 M | -2.703 M | -3.277 M | -2.669 M | -5.401 M | -3.456 M | -9.437 M | |
| Depreciation | 33.000 K | 33.000 K | 33.000 K | 33.000 K | 32.000 K | 33.000 K | 33.000 K | 25.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 12.000 K | 1.000 K | 4.000 K | 6.000 K | 6.000 K | 71.000 K | 57.000 K | 65.000 K | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | -10.000 M | 0.000 | 0.000 | 0.000 | -14.000 K | |
| Net Borrowings | 12.011 M | 14.460 M | 15.675 M | 28.312 M | 31.667 M | 1.149 M | 3.668 M | 1.567 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -14.000 K | |
| Cash Change | 702.000 K | 466.000 K | 645.000 K | 280.000 K | 261.000 K | 397.000 K | 345.000 K | 8.706 M |